Concepts (107)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Transportation | 1 | 2021 | 5 | 0.760 |
Why?
|
| Walking | 1 | 2021 | 130 | 0.670 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 2 | 2014 | 15 | 0.560 |
Why?
|
| Ubiquitin | 2 | 2014 | 24 | 0.490 |
Why?
|
| Ubiquitination | 1 | 2014 | 32 | 0.470 |
Why?
|
| KATP Channels | 1 | 2014 | 2 | 0.460 |
Why?
|
| Connexins | 1 | 2014 | 2 | 0.460 |
Why?
|
| Mitochondrial Turnover | 1 | 2013 | 2 | 0.460 |
Why?
|
| Mitochondria | 2 | 2014 | 329 | 0.460 |
Why?
|
| Muscle Cells | 1 | 2013 | 15 | 0.450 |
Why?
|
| Infrared Rays | 1 | 2013 | 23 | 0.450 |
Why?
|
| Hyperglycemia | 1 | 2014 | 77 | 0.430 |
Why?
|
| Muscle, Skeletal | 4 | 2013 | 578 | 0.430 |
Why?
|
| Insulin | 2 | 2014 | 310 | 0.430 |
Why?
|
| Diabetes Mellitus | 1 | 2014 | 207 | 0.380 |
Why?
|
| Nuclear Respiratory Factor 1 | 1 | 2011 | 4 | 0.380 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2011 | 13 | 0.380 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2011 | 45 | 0.380 |
Why?
|
| Muscle Contraction | 2 | 2013 | 161 | 0.370 |
Why?
|
| Gene Expression | 1 | 2011 | 406 | 0.330 |
Why?
|
| Signal Transduction | 1 | 2013 | 1337 | 0.290 |
Why?
|
| Aging | 4 | 2014 | 943 | 0.240 |
Why?
|
| Calcium | 3 | 2014 | 231 | 0.230 |
Why?
|
| Mitochondria, Muscle | 3 | 2013 | 39 | 0.210 |
Why?
|
| Physical Conditioning, Animal | 2 | 2013 | 34 | 0.210 |
Why?
|
| Exercise | 2 | 2021 | 442 | 0.200 |
Why?
|
| Belgium | 1 | 2021 | 2 | 0.190 |
Why?
|
| Environment Design | 1 | 2021 | 13 | 0.190 |
Why?
|
| Residence Characteristics | 1 | 2021 | 100 | 0.180 |
Why?
|
| Animals | 7 | 2014 | 9932 | 0.170 |
Why?
|
| Rats | 4 | 2014 | 1539 | 0.140 |
Why?
|
| Mice | 3 | 2014 | 4396 | 0.130 |
Why?
|
| Sarcopenia | 2 | 2013 | 41 | 0.130 |
Why?
|
| Mitochondrial Proteins | 2 | 2013 | 72 | 0.130 |
Why?
|
| Homeostasis | 2 | 2014 | 114 | 0.130 |
Why?
|
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 2 | 2014 | 15 | 0.130 |
Why?
|
| Polyubiquitin | 1 | 2014 | 1 | 0.120 |
Why?
|
| Aged | 3 | 2021 | 5157 | 0.120 |
Why?
|
| Testis | 1 | 2014 | 39 | 0.120 |
Why?
|
| Islets of Langerhans | 1 | 2014 | 9 | 0.120 |
Why?
|
| Lysine | 1 | 2014 | 69 | 0.120 |
Why?
|
| Physical Exertion | 1 | 2014 | 98 | 0.120 |
Why?
|
| Insulin-Secreting Cells | 1 | 2014 | 10 | 0.110 |
Why?
|
| Calcium Signaling | 1 | 2014 | 68 | 0.110 |
Why?
|
| Animals, Newborn | 1 | 2014 | 163 | 0.110 |
Why?
|
| Transcription Factors | 3 | 2014 | 511 | 0.110 |
Why?
|
| Hypoxia | 1 | 2013 | 84 | 0.110 |
Why?
|
| Caloric Restriction | 1 | 2013 | 73 | 0.100 |
Why?
|
| Stilbenes | 1 | 2013 | 90 | 0.100 |
Why?
|
| Mice, Transgenic | 1 | 2014 | 487 | 0.100 |
Why?
|
| Blood Glucose | 1 | 2014 | 300 | 0.100 |
Why?
|
| Mice, Knockout | 1 | 2014 | 780 | 0.090 |
Why?
|
| RNA-Binding Proteins | 1 | 2011 | 82 | 0.090 |
Why?
|
| Prostatic Neoplasms | 1 | 2013 | 270 | 0.090 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 323 | 0.090 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2009 | 20 | 0.080 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2011 | 542 | 0.080 |
Why?
|
| Blotting, Western | 1 | 2011 | 503 | 0.080 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2010 | 119 | 0.080 |
Why?
|
| Transcription, Genetic | 1 | 2009 | 399 | 0.070 |
Why?
|
| Time Factors | 1 | 2011 | 1564 | 0.070 |
Why?
|
| Male | 5 | 2014 | 12842 | 0.070 |
Why?
|
| Humans | 4 | 2021 | 26777 | 0.060 |
Why?
|
| Rats, Inbred F344 | 2 | 2014 | 167 | 0.060 |
Why?
|
| AMP-Activated Protein Kinases | 2 | 2013 | 31 | 0.050 |
Why?
|
| MAP Kinase Signaling System | 2 | 2014 | 93 | 0.050 |
Why?
|
| Adenosine Triphosphate | 2 | 2014 | 115 | 0.050 |
Why?
|
| Apoptosis | 2 | 2014 | 738 | 0.040 |
Why?
|
| Oxidative Stress | 2 | 2014 | 623 | 0.040 |
Why?
|
| NF-E2-Related Factor 1 | 1 | 2014 | 3 | 0.030 |
Why?
|
| Atrophy | 1 | 2014 | 14 | 0.030 |
Why?
|
| Exocytosis | 1 | 2014 | 13 | 0.030 |
Why?
|
| DNA, Mitochondrial | 1 | 2014 | 82 | 0.030 |
Why?
|
| Vasoconstriction | 1 | 2013 | 41 | 0.030 |
Why?
|
| Adaptation, Physiological | 1 | 2014 | 158 | 0.030 |
Why?
|
| Random Allocation | 1 | 2013 | 148 | 0.030 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2013 | 33 | 0.030 |
Why?
|
| Organ Size | 1 | 2013 | 83 | 0.030 |
Why?
|
| Sirtuin 1 | 1 | 2013 | 39 | 0.030 |
Why?
|
| Microcirculation | 1 | 2013 | 111 | 0.030 |
Why?
|
| Antioxidants | 1 | 2014 | 221 | 0.030 |
Why?
|
| Oxygen Consumption | 1 | 2013 | 173 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2013 | 290 | 0.030 |
Why?
|
| Oxygen | 1 | 2013 | 217 | 0.030 |
Why?
|
| Glucose | 1 | 2014 | 191 | 0.030 |
Why?
|
| Models, Biological | 1 | 2014 | 446 | 0.020 |
Why?
|
| Protein Stability | 1 | 2010 | 42 | 0.020 |
Why?
|
| Catalytic Domain | 1 | 2010 | 77 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 2010 | 86 | 0.020 |
Why?
|
| Cysteine | 1 | 2010 | 67 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2014 | 1258 | 0.020 |
Why?
|
| HeLa Cells | 1 | 2010 | 206 | 0.020 |
Why?
|
| Organelle Biogenesis | 1 | 2009 | 10 | 0.020 |
Why?
|
| Middle Aged | 2 | 2012 | 6796 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2010 | 283 | 0.020 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2009 | 44 | 0.020 |
Why?
|
| Protein Biosynthesis | 1 | 2009 | 106 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 2010 | 353 | 0.020 |
Why?
|
| Adult | 2 | 2012 | 7359 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2010 | 673 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2013 | 1392 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2010 | 1034 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2012 | 1924 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2009 | 645 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2009 | 628 | 0.020 |
Why?
|
| Young Adult | 1 | 2012 | 2576 | 0.020 |
Why?
|
| Female | 1 | 2012 | 14421 | 0.010 |
Why?
|